Sort by
Refine Your Search
-
for heterogeneous data integration, designing scalable architectures for Big Data, and building intelligent decision support systems. Where to apply Website http://www.icar.cnr.it Requirements Additional Information
-
Sclerosis, Alzheimer's disease, Parkinson's disease, stroke, mood disorders, and others). Non-clinical evaluations are also sometimes completed, which may relate to issues such as disability status. A
-
expert in epigenomic and transcriptomic mechanisms that contribute to neurodegeneration in Parkinsons and Alzheimers diseases, the incumbent collaborates closely with the Principal Investigator (PI
-
biology Biochemistry Genetics Biology of organ systems Brain dysfunction and repair Disorders such as Alzheimer's disease, Parkinsonism, schizophrenia, and depression Examples of the curricular programs can
-
of accelerating discoveries about brain function and developing treatments for diseases such as Alzheimer's, Parkinson's, multiple sclerosis, epilepsy, depression, paraplegia and tetraplegia. CONTEXT The Paris
-
. The mission of the lab is to follow a network-based approach to understand the pathogenesis of neurodegenerative diseases (mainly Parkinson's disease and secondarily Alzheimer's disease), with the ultimate aim
-
fibrils associated with the onset of neurodegenerative conditions including Alzheimer's, Parkinson's and ALS. Methods include x-ray diffraction, electron microscopy, and cellular and animal assays Job
-
term, these technologies could enable the development of intelligent therapeutic devices for the treatment of neurological and psychiatric disorders such as epilepsy, Parkinson's disease, treatment
-
, cognitive functioning, Parkinson's Disease, HIV and aging, chronic care and disease management, trauma and emergency care, knee osteoarthritis, gero-science informed omics, and global aging. The Division
-
University of Texas Health Science Center San Antonio | San Antonio, Texas | United States | about 3 hours ago
treatment of Alzheimer's disease and other neurodegenerative conditions, including vascular contributions to dementia, Parkinson's and Lewy body dementia, chronic traumatic encephalopathy and frontotemporal